Clinical Trials Browser

Phase 2 × OTHER × seribantumab × Clear all

NCT04790695 2022-01-12

Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms